Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 64Leukemia 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 62Myelodysplastic Syndromes 56Leukemia, Lymphocytic, Chronic, B-Cell 54Multiple Myeloma 49Lymphoma, Non-Hodgkin 49Hodgkin Disease 47Lymphoma, Mantle-Cell 41Lymphoma, Large B-Cell, Diffuse 39Lymphoma, Follicular 39Leukemia, Myeloid, Chronic-Phase 39Lymphoma, B-Cell, Marginal Zone 35Lymphoma 35Burkitt Lymphoma 35Lymphoma, Large-Cell, Immunoblastic 34Myeloproliferative Disorders 33Congenital Abnormalities 32Leukemia, Myeloid, Accelerated Phase 31Anemia, Refractory, with Excess of Blasts 30Leukemia, Myelomonocytic, Chronic 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Dendritic Cell Sarcoma, Interdigitating 23Blast Crisis 23Waldenstrom Macroglobulinemia 21Recurrence 21Lymphoma, T-Cell, Cutaneous 20Anemia, Refractory 19Sezary Syndrome 18Graft vs Host Disease 18

Interventions

pimodivir 1Sunitinib 1Rosuvastatin Calcium 1Olive Oil 1Midazolam 1Interviews as Topic 1Cyclosporine 1Control Groups 1Blood Specimen Collection 1Adalimumab 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Healthy × Cyclosporine × Clear all
NCT03768609 2019-04-29

A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults

Janssen-Cilag International NV

Phase 1 Completed
18 enrolled

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡